High level of ATAD2 expression was correlated with lymph node metastasis and advanced clinical stage and predicted poor overall survival in ESCC patients, which indicated an oncogenic role of ATAD2 in ESCC. This evidence concerns the gene ATAD2 and esophageal squamous cell carcinoma.